Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
03/31/2004 | CN1486177A Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
03/31/2004 | CN1486176A Pharmaceutical compositions comprising amlodipine maleate |
03/31/2004 | CN1486175A Powdery preparations and proecss for producing the same |
03/31/2004 | CN1485362A Ion cross-linked chitosan microballoon, its preparing process and use |
03/31/2004 | CN1485343A Production method of specific IgY for venereal disease and its combined preparation |
03/31/2004 | CN1485094A Natural porous polymer beads, the preparation and application thereof |
03/31/2004 | CN1485088A Cinese material medical preparation for curing children' hyperkinetic symptom and the preparation process thereof |
03/31/2004 | CN1485086A Peroral Chinese medicine powder for treating bone fracture and its preparing process |
03/31/2004 | CN1485085A Appetizing promoting digestion oral liquid and the preparation thereof |
03/31/2004 | CN1485084A A reducing fever anti-cold medicine combination and the preparation process thereof |
03/31/2004 | CN1485083A Capsule for thyroid cancer / tumor and lymph node |
03/31/2004 | CN1485082A Blumea oil soft capsule |
03/31/2004 | CN1485081A Buccal tablets for curing acute or chronic pharyngitis and buccal inflammation and the preparation technology thereof |
03/31/2004 | CN1485080A Navel compressing expectorate-easing ointment and the producing method thereof |
03/31/2004 | CN1485075A Lotion for treating hyperosteogeny |
03/31/2004 | CN1485072A Coix seed oil soft capsule for curing prostate diseases and the application thereof |
03/31/2004 | CN1485068A Paster of external use for lumbocrural pain |
03/31/2004 | CN1485061A Gingko leaf drop pill |
03/31/2004 | CN1485045A Medication composition dispelling wind, facilitating ATP synthesis, building up immune competency |
03/31/2004 | CN1485043A Adetphos sodium chloride injection and its preparation method |
03/31/2004 | CN1485041A Hemin chewing tablet and its preparation method |
03/31/2004 | CN1485038A Fibrauretine powder and injection preparation |
03/31/2004 | CN1485036A Compound demerol formulation |
03/31/2004 | CN1485034A Rifaximin suspension mix granule formulation |
03/31/2004 | CN1485033A Rifaximin capsule |
03/31/2004 | CN1485031A Medication oral liquid |
03/31/2004 | CN1485028A Lycopene drop pill |
03/31/2004 | CN1485027A Liposome anti-fungus medication sprayer formulation |
03/31/2004 | CN1485026A Intravenous injection liquid preparing method of oxygen-enriched broad transfusion |
03/31/2004 | CN1484972A Anti-diarrhea yelk antibody feed additive for swine and injection formulation, and preparation method |
03/31/2004 | CN1484966A Compound tea encapsulating moulding method |
03/31/2004 | CN1143859C Camptothecin derivative and its preparation |
03/31/2004 | CN1143689C Aqueous coated composition and method for preparing solid medicine formulation |
03/31/2004 | CN1143688C Triacetin as transdermal permeation enhancer |
03/31/2004 | CN1143683C Exterior-applied black plaster for treating bone diseases and its preparing process |
03/31/2004 | CN1143679C Method and material for treating and preventing mucosal tissue inflammation |
03/31/2004 | CN1143678C Use of VC-magnesium phosphate ester in preparation of medication for constipation |
03/31/2004 | CN1143673C Improvement in the taste of active pharmaceutical ingredients |
03/31/2004 | CN1143672C Pharmaceutical compositions comprising uridine triphosphate |
03/30/2004 | US6713772 Free-form fabrication using multi-photon excitation |
03/30/2004 | US6713616 Detecting binding |
03/30/2004 | US6713533 Nanocapsules and method of production thereof |
03/30/2004 | US6713509 High molecular weight crosslinked acrylic acid polymer, dibasic calcium phosphate and phosphodiesterase isozyme denominated 4 inhibitor; chronic obstructive pulmonary disease (copd) |
03/30/2004 | US6713495 Magnesium omeprazole |
03/30/2004 | US6713470 Method of treatment |
03/30/2004 | US6713461 Eletriptan and sulphobutylether-beta-cyclodextrin; well tolerated intranasal delivery; bioavailability; fast acting |
03/30/2004 | US6713454 Prodrugs of etoposide and etoposide analogs |
03/30/2004 | US6713446 Boronic acid compounds obtained by lyophilization of an aqueous mixture of the boronic acid compound and a sugar having at least two hydroxyl groups; shelf life |
03/30/2004 | US6713293 Encapsulated cells containing an amplified expression vector as a drug delivery device |
03/30/2004 | US6713176 Processing and manufacturing methods enabled using non-stoichiometric nanomaterials |
03/30/2004 | US6713097 Use of a preparation of cimicifuga racemosa |
03/30/2004 | US6713090 Apparatus and method for preparing microparticles |
03/30/2004 | US6713089 Under acidic conditions; nonsteroid antiinflammatory nsaid; crushing strength |
03/30/2004 | US6713087 Method of producing submicron particles of a labile agent and use thereof |
03/30/2004 | US6713086 Side effect reduction, treatment of migraine, epilepsy, mania associated with a bipolar disorders, once a day dosage, an oral osmotic pump formulations, containing hydroxypropyl-methyl cellulose |
03/30/2004 | US6713083 Porous core of a first bioabsorbable material and a substantially non-porous layer of a second bioabsorbable material around the core. |
03/30/2004 | US6713081 Ocular therapeutic agent delivery devices and methods for making and using such devices |
03/30/2004 | US6713079 Contacting the site of wound with a matrix comprising gelatin and a nitric oxide scavanger to increase blood cirulation; nitric oxide scavanger are selected from l-arganine analog, dextran, heparin, cysteine and cystine |
03/30/2004 | US6713073 Whole body spray |
03/30/2004 | US6713048 Δ9 tetrahydrocannabinol (Δ9 THC) solution metered dose inhalers and methods of use |
03/30/2004 | US6713047 Mixture of hfa 134a and hfa 227 allows modulation of the mass median aerodynamic diameter (mmad) of the aerosol particles to target specific regions of the repiratory tract |
03/30/2004 | US6712803 Drug dispensing system |
03/30/2004 | US6712782 Brachytherapy apparatus and methods |
03/30/2004 | US6712610 Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy and method |
03/30/2004 | US6712121 Antimicrobially-treated fabrics |
03/30/2004 | CA2304110C Theophylline sustained release tablet |
03/30/2004 | CA2296231C Composition and method for treating common viral infections |
03/30/2004 | CA2201611C Saponin preparations and use thereof in iscoms |
03/30/2004 | CA2178602C Microcapsules, method of making and their use |
03/30/2004 | CA2162993C Solid fat nanoemulsions as drug delivery vehicles |
03/30/2004 | CA2152907C Antiviral topical pharmaceutical compositions |
03/30/2004 | CA2148043C Solid pharmaceutical dosage form containing flavored film coating |
03/30/2004 | CA2136233C Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
03/30/2004 | CA2136103C Antibiotic cryptdin peptides and methods of their use |
03/30/2004 | CA2127805C Composition for nasal administration |
03/30/2004 | CA2109065C Bioartificial endocrine device |
03/30/2004 | CA2103518C Production of microcapsules of water-soluble drugs |
03/30/2004 | CA2067924C N-alkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them |
03/25/2004 | WO2004025416A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
03/25/2004 | WO2004024919A1 Non-sequence complementary antiviral oligonucleotides |
03/25/2004 | WO2004024868A2 Product and process for liquefaction of mucus or sputum |
03/25/2004 | WO2004024777A1 Hydroxyalkyl starch derivatives |
03/25/2004 | WO2004024776A1 Method of producing hydroxyalkyl starch derivatives |
03/25/2004 | WO2004024761A1 Hasylated polypeptides, especially hasylated erythropoietin |
03/25/2004 | WO2004024754A1 Proline ester and preparation containing the same for percutaneous administration |
03/25/2004 | WO2004024695A1 Novel molecules derived from noraporphine |
03/25/2004 | WO2004024669A1 Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
03/25/2004 | WO2004024343A1 Precipitation of solid particles from droplets formed using focused acoustic energy |
03/25/2004 | WO2004024339A1 Method and apparatus for applying powder in a pattern to a substrate |
03/25/2004 | WO2004024226A1 Device for delivering a viscous medical solution to the nasal membrane and method for using same |
03/25/2004 | WO2004024225A1 System and method for delivering a composition to the nasal membrane |
03/25/2004 | WO2004024213A2 Aerosolized capreomycin for inhibition of pulmonary tuberculosis |
03/25/2004 | WO2004024211A2 Method and device for painless injection of medication |
03/25/2004 | WO2004024209A2 Materials and methods for drug delivery and uptake |
03/25/2004 | WO2004024187A2 Compositions to reduce congestion and methods for application thereof to the nasal membrane |
03/25/2004 | WO2004024184A1 Sustained release preparation |
03/25/2004 | WO2004024175A1 Cancer antigen peptide preparation |
03/25/2004 | WO2004024168A1 Composition and method for use in intestinal cleansing procedures |
03/25/2004 | WO2004024164A1 Stable eye drops containing latanoprost as the active ingredient |
03/25/2004 | WO2004024155A1 Adhesive patch |